Antibody-Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data

In this study, we have thoroughly completed a narrative review of the current literature and summarized preclinical studies and clinical trials that evaluated the utility, activity, and toxicity of ADCs in GU cancers, the prospects of ADC development, and the ongoing clinical trials. Prospective clinical trials, retrospective studies, case reports, and scoping reviews were included.PMID:38668075 | DOI:10.3390/curroncol31040172
Source: Current Oncology - Category: Cancer & Oncology Authors: Source Type: research